By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Sin...
| Profit Statement | 2027 | 2028 | 2029 | |
| Sales | CZK mil | 773 | 1,000 | 1,270 |
| Gross Profit | CZK mil | 232 | 287 | 350 |
| EBITDA | CZK mil | 134 | 160 | 183 |
| EBIT | CZK mil | 128 | 156 | 180 |
| Financing Cost | CZK mil | 3.85 | 0.627 | -2.55 |
| Pre-Tax Profit | CZK mil | 124 | 155 | 182 |
| Net Profit | CZK mil | 106 | 126 | 148 |
| Dividends | CZK mil | 41.4 | 76.4 | 91.5 |
| Balance Sheet | 2027 | 2028 | 2029 | |
| Total Assets | CZK mil | 283 | 307 | 338 |
| Non-Current Assets | CZK mil | 169 | 169 | 172 |
| Current Assets | CZK mil | 114 | 138 | 166 |
| Working Capital | CZK mil | 64.8 | 85.3 | 110 |
| Shareholders' Equity | CZK mil | 244 | 328 | 399 |
| Liabilities | CZK mil | 39.3 | -20.8 | -61.5 |
| Total Debt | CZK mil | 12.5 | -51.0 | -94.9 |
| Net Debt | CZK mil | -17.5 | -81.0 | -125 |
| Ratios | 2027 | 2028 | 2029 | |
| ROE | % | 39.9 | 35.6 | 33.5 |
| ROCE | % | 46.2 | 51.6 | 55.0 |
| Gross Margin | % | 30.0 | 28.7 | 27.6 |
| EBITDA Margin | % | 17.3 | 16.0 | 14.4 |
| EBIT Margin | % | 16.6 | 15.6 | 14.2 |
| Net Margin | % | 13.7 | 12.6 | 11.6 |
| Net Debt/EBITDA | -0.131 | -0.506 | -0.682 | |
| Net Debt/Equity | % | -7.17 | -24.7 | -31.3 |
| Cost of Financing | % | 5.00 | 5.00 | 5.00 |
| Valuation | 2027 | 2028 | 2029 | |
| Market Capitalisation | USD mil | 11.8 | 11.8 | 11.8 |
| Enterprise Value (EV) | USD mil | 11.0 | 7.98 | 5.93 |
| Number Of Shares | mil | 1.00 | 1.00 | 1.00 |
| Share Price | CZK | 252 | 252 | 252 |
| EV/EBITDA | 1.80 | 1.10 | 0.713 | |
| EV/Sales | 0.312 | 0.176 | 0.103 | |
| Price/Earnings (P/E) | 3.04 | 2.47 | 2.06 | |
| Price/Book Value (P/BV) | 1.03 | 0.767 | 0.630 | |
| Dividend Yield | % | 16.4 | 30.3 | 36.4 |
Get all company financials in excel:
| overview | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| income statement | |||||||||||||
| Sales | CZK mil | 3.29 | 4.88 | 4.26 | 18.2 | ||||||||
| Gross Profit | CZK mil | 3.46 | -7.93 | -8.50 | -6.30 | ||||||||
| EBIT | CZK mil | -16.7 | -31.7 | -31.9 | -34.5 | ||||||||
| Net Profit | CZK mil | -16.9 | -32.1 | -31.9 | -37.2 | ||||||||
| ROE | % | ... | ... | -41.7 | -29.8 | ||||||||
| EBIT Margin | % | -509 | -651 | -747 | -189 | ||||||||
| Net Margin | % | -512 | -658 | -748 | -204 | ||||||||
| balance sheet | |||||||||||||
| Total Assets | CZK mil | ... | 139 | 130 | 137 | ||||||||
| Non-Current Assets | CZK mil | ... | 119 | 120 | 126 | ||||||||
| Current Assets | CZK mil | ... | 18.2 | 8.88 | 11.5 | ||||||||
| Shareholders' Equity | CZK mil | ... | 78.0 | 75.0 | 100 | ||||||||
| Liabilities | CZK mil | ... | 60.5 | 54.5 | 37.0 | ||||||||
| Non-Current Liabilities | CZK mil | ... | 47.1 | 22.6 | 22.6 | ||||||||
| Current Liabilities | CZK mil | ... | 12.0 | 30.6 | 14.4 | ||||||||
| Net Debt/EBITDA | ... | -2.47 | -2.09 | -0.985 | |||||||||
| Net Debt/Equity | % | ... | 72.7 | 62.6 | 25.2 | ||||||||
| Cost of Financing | % | ... | ... | 0.087 | 5.80 | ||||||||
| cash flow | |||||||||||||
| Total Cash From Operations | CZK mil | ... | ... | ... | -25.5 | ||||||||
| Total Cash From Investing | CZK mil | ... | ... | ... | -2.95 | ||||||||
| Total Cash From Financing | CZK mil | ... | ... | ... | 33.3 | ||||||||
| Net Change In Cash | CZK mil | ... | ... | ... | 4.88 | ||||||||
| valuation | |||||||||||||
| Market Capitalisation | USD mil | ... | ... | 11.8 | 11.8 | ||||||||
| Enterprise Value (EV) | USD mil | ... | ... | 14.0 | 12.9 | ||||||||
| Number Of Shares | mil | ... | ... | 1.00 | 1.00 | ||||||||
| Share Price | CZK | ... | ... | 252 | 252 | ||||||||
| Price/Earnings (P/E) | ... | ... | -7.89 | -9.13 | |||||||||
| Price/Cash Earnings (P/CE) | ... | ... | -11.2 | -8.88 | |||||||||
| EV/EBITDA | ... | ... | -13.6 | -11.1 | |||||||||
| Price/Book Value (P/BV) | ... | ... | 3.36 | 2.51 | |||||||||
| Dividend Yield | % | ... | ... | 0 | 0 |
| income statement | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| income statement | |||||||||||||
| Sales | CZK mil | 3.29 | 4.88 | 4.26 | 18.2 | ||||||||
| Cost of Goods & Services | CZK mil | -0.173 | 12.8 | 12.8 | 24.5 | ||||||||
| Gross Profit | CZK mil | 3.46 | -7.93 | -8.50 | -6.30 | ||||||||
| Staff Cost | CZK mil | 7.59 | 10.0 | 9.83 | 12.4 | ||||||||
| EBITDA | CZK mil | -7.78 | -23.0 | -22.5 | -25.6 | ||||||||
| Depreciation | CZK mil | 8.96 | 8.73 | 9.35 | 8.88 | ||||||||
| EBIT | CZK mil | -16.7 | -31.7 | -31.9 | -34.5 | ||||||||
| Net Financing Cost | CZK mil | 0.116 | 0.336 | 0.046 | 2.73 | ||||||||
| Financing Cost | CZK mil | 0.116 | 0.336 | 0.046 | 2.73 | ||||||||
| Financing Income | CZK mil | 0 | 0 | 0 | 0 | ||||||||
| FX (Gain) Loss | CZK mil | 0 | 0 | 0 | 0 | ||||||||
| Extraordinary Cost | CZK mil | 0 | 0 | 0 | 0 | ||||||||
| Pre-Tax Profit | CZK mil | -16.9 | -32.1 | -31.9 | -37.2 | ||||||||
| Tax | CZK mil | 0 | 0 | 0 | 0 | ||||||||
| Minorities | CZK mil | 0 | 0 | 0 | -9.68 | ||||||||
| Net Profit | CZK mil | -16.9 | -32.1 | -31.9 | -37.2 | ||||||||
| Net Profit Avail. to Common | CZK mil | -16.9 | -32.1 | -31.9 | -27.6 | ||||||||
| Dividends | CZK mil | 0 | 0 | 0 | 0 | ||||||||
| growth rates | |||||||||||||
| Total Revenue Growth | % | ... | 48.1 | -12.5 | 327 | ||||||||
| Operating Cost Growth | % | ... | 38.9 | -17.4 | 65.7 | ||||||||
| Staff Cost Growth | % | ... | 31.9 | -1.84 | 26.1 | ||||||||
| EBITDA Growth | % | ... | 196 | -2.14 | 13.8 | ||||||||
| EBIT Growth | % | ... | 89.6 | 0.387 | 8.28 | ||||||||
| Pre-Tax Profit Growth | % | ... | 90.3 | -0.521 | 16.7 | ||||||||
| Net Profit Growth | % | ... | 90.3 | -0.521 | -13.6 | ||||||||
| ratios | |||||||||||||
| ROE | % | ... | ... | -41.7 | -29.8 | ||||||||
| ROA | % | ... | ... | -23.8 | -27.9 | ||||||||
| ROCE | % | ... | ... | -24.2 | -28.6 | ||||||||
| Gross Margin | % | 105 | -163 | -199 | -34.6 | ||||||||
| EBITDA Margin | % | -236 | -472 | -528 | -141 | ||||||||
| EBIT Margin | % | -509 | -651 | -747 | -189 | ||||||||
| Net Margin | % | -512 | -658 | -748 | -204 | ||||||||
| Payout Ratio | % | 0 | 0 | 0 | 0 | ||||||||
| Cost of Financing | % | ... | ... | 0.087 | 5.80 | ||||||||
| Net Debt/EBITDA | ... | -2.47 | -2.09 | -0.985 |
| balance sheet | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| balance sheet | |||||||||||||
| Cash & Cash Equivalents | CZK mil | ... | 2.15 | 0.124 | 5.00 | ||||||||
| Receivables | CZK mil | ... | 16.0 | 8.75 | 5.47 | ||||||||
| Inventories | CZK mil | ... | 0 | 0 | 1.00 | ||||||||
| Other ST Assets | CZK mil | ... | 0 | < 0.001 | < 0.001 | ||||||||
| Current Assets | CZK mil | ... | 18.2 | 8.88 | 11.5 | ||||||||
| Property, Plant & Equipment | CZK mil | ... | 0.036 | 0.011 | 1.48 | ||||||||
| LT Investments & Receivables | CZK mil | ... | 119 | 120 | 123 | ||||||||
| Intangible Assets | CZK mil | ... | 0 | 0 | 1.48 | ||||||||
| Goodwill | CZK mil | ... | 0 | 0 | 0 | ||||||||
| Non-Current Assets | CZK mil | ... | 119 | 120 | 126 | ||||||||
| Total Assets | CZK mil | ... | 139 | 130 | 137 | ||||||||
| Trade Payables | CZK mil | ... | 0.212 | 0.182 | 0.732 | ||||||||
| Short-Term Debt | CZK mil | ... | 11.8 | 24.5 | 7.63 | ||||||||
| Other ST Liabilities | CZK mil | ... | 0.014 | 5.90 | 6.08 | ||||||||
| Current Liabilities | CZK mil | ... | 12.0 | 30.6 | 14.4 | ||||||||
| Long-Term Debt | CZK mil | ... | 47.1 | 22.6 | 22.6 | ||||||||
| Other LT Liabilities | CZK mil | ... | 0 | 0 | 0 | ||||||||
| Non-Current Liabilities | CZK mil | ... | 47.1 | 22.6 | 22.6 | ||||||||
| Liabilities | CZK mil | ... | 60.5 | 54.5 | 37.0 | ||||||||
| Equity Before Minority Interest | CZK mil | ... | 78.0 | 75.0 | 110 | ||||||||
| Minority Interest | CZK mil | ... | 0 | 0 | -9.68 | ||||||||
| Equity | CZK mil | ... | 78.0 | 75.0 | 100 | ||||||||
| growth rates | |||||||||||||
| Total Asset Growth | % | ... | ... | -6.50 | 6.01 | ||||||||
| Shareholders' Equity Growth | % | ... | ... | -3.84 | 33.7 | ||||||||
| Net Debt Growth | % | ... | ... | -17.2 | -46.3 | ||||||||
| Total Debt Growth | % | ... | ... | -20.0 | -35.8 | ||||||||
| ratios | |||||||||||||
| Total Debt | CZK mil | ... | 58.9 | 47.1 | 30.2 | ||||||||
| Net Debt | CZK mil | ... | 56.7 | 47.0 | 25.2 | ||||||||
| Working Capital | CZK mil | ... | 15.8 | 8.57 | 5.73 | ||||||||
| Capital Employed | CZK mil | ... | 135 | 128 | 132 | ||||||||
| Net Debt/Equity | % | ... | 72.7 | 62.6 | 25.2 | ||||||||
| Current Ratio | ... | 1.52 | 0.290 | 0.794 | |||||||||
| Quick Ratio | ... | 1.52 | 0.290 | 0.725 |
| cash flow | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| cash flow | |||||||||||||
| Net Profit | CZK mil | -16.9 | -32.1 | -31.9 | -37.2 | ||||||||
| Depreciation | CZK mil | 8.96 | 8.73 | 9.35 | 8.88 | ||||||||
| Non-Cash Items | CZK mil | ... | ... | ... | 0 | ||||||||
| Change in Working Capital | CZK mil | ... | ... | ... | 2.84 | ||||||||
| Total Cash From Operations | CZK mil | ... | ... | ... | -25.5 | ||||||||
| Capital Expenditures | CZK mil | ... | ... | ... | -2.95 | ||||||||
| Net Change in LT Investment | CZK mil | ... | ... | ... | 0 | ||||||||
| Total Cash From Investing | CZK mil | ... | ... | ... | -2.95 | ||||||||
| Dividends Paid | CZK mil | ... | ... | ... | 0 | ||||||||
| Issuance Of Shares | CZK mil | ... | ... | ... | 62.5 | ||||||||
| Issuance Of Debt | CZK mil | ... | ... | ... | -16.9 | ||||||||
| Total Cash From Financing | CZK mil | ... | ... | ... | 33.3 | ||||||||
| Effect of FX Rates | CZK mil | ... | ... | ... | 0 | ||||||||
| Net Change In Cash | CZK mil | ... | ... | ... | 4.88 | ||||||||
| ratios | |||||||||||||
| Days Sales Outstanding | days | ... | 1,201 | 749 | 110 | ||||||||
| Days Sales Of Inventory | days | ... | 0 | 0 | 14.9 | ||||||||
| Days Payable Outstanding | days | ... | 6.04 | 5.20 | 10.9 | ||||||||
| Cash Conversion Cycle | days | ... | 1,195 | 744 | 113 | ||||||||
| Cash Earnings | CZK mil | -7.89 | -23.3 | -22.6 | -28.4 | ||||||||
| Free Cash Flow | CZK mil | ... | ... | ... | -28.5 | ||||||||
| Capital Expenditures (As % of Sales) | % | ... | ... | ... | 16.2 |
| other ratios | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| Operating Cost (As % of Sales) | % | 111 | 104 | 98.2 | 38.1 | ||||||||
| Staff Cost (As % of Sales) | % | 231 | 205 | 230 | 68.0 | ||||||||
| Effective Tax Rate | % | 0 | 0 | 0 | 0 | ||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | |||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
| valuation | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| Market Capitalisation | USD mil | ... | ... | 11.8 | 11.8 | ||||||||
| Enterprise Value (EV) | USD mil | ... | ... | 14.0 | 12.9 | ||||||||
| Number Of Shares | mil | ... | ... | 1.00 | 1.00 | ||||||||
| Share Price | CZK | ... | ... | 252 | 252 | ||||||||
| EV/EBITDA | ... | ... | -13.6 | -11.1 | |||||||||
| Price/Earnings (P/E) | ... | ... | -7.89 | -9.13 | |||||||||
| Price/Cash Earnings (P/CE) | ... | ... | -11.2 | -8.88 | |||||||||
| P/FCF | ... | ... | ... | -8.84 | |||||||||
| Price/Book Value (P/BV) | ... | ... | 3.36 | 2.51 | |||||||||
| Dividend Yield | % | ... | ... | 0 | 0 | ||||||||
| Free Cash Flow Yield | % | ... | ... | ... | -11.0 | ||||||||
| Earnings Per Share (EPS) | CZK | ... | ... | -31.9 | -27.6 | ||||||||
| Cash Earnings Per Share | CZK | ... | ... | -22.6 | -28.4 | ||||||||
| Free Cash Flow Per Share | CZK | ... | ... | ... | -28.5 | ||||||||
| Book Value Per Share | CZK | ... | ... | 75.0 | 100 | ||||||||
| Dividend Per Share | CZK | ... | ... | 0 | 0 | ||||||||
| EV/Sales | ... | ... | 72.1 | 15.6 | |||||||||
| EV/EBIT | ... | ... | -9.64 | -8.26 | |||||||||
| EV/Free Cash Flow | ... | ... | ... | -10.0 | |||||||||
| EV/Capital Employed | ... | ... | 2.32 | 2.10 | |||||||||
| Earnings Per Share Growth | % | ... | ... | ... | -13.6 | ||||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | 25.7 | ||||||||
| Book Value Per Share Growth | % | ... | ... | ... | 33.7 |
| simplecell networks | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| income statement | |||||||||||||
| Sales (Networks) | CZK mil | 3.29 | 4.88 | 4.26 | 6.71 | ||||||||
| Czech connections registered (Networks) | '000 | ... | ... | 56.1 | 101 | ||||||||
| Czech connections activated (Networks) | '000 | ... | ... | 22.4 | 40.4 | ||||||||
| Activated as % of Connected (Networks) | % | ... | ... | 40.0 | 40.0 | ||||||||
| ARPU per Connection (Networks) | CZK | ... | ... | 175 | 166 | ||||||||
| Cost of Goods & Services (Networks) | CZK mil | -0.173 | 12.8 | 12.8 | 15.4 | ||||||||
| Sigfox - 40% of Sales (Networks) | CZK mil | 0.750 | 1.46 | 1.71 | 2.68 | ||||||||
| T-Mobile (Networks) | CZK mil | 0.809 | 12.8 | 12.3 | 12.7 | ||||||||
| Gross Profit (Networks) | CZK mil | 3.46 | -7.93 | -8.50 | -8.70 | ||||||||
| EBITDA (Networks) | CZK mil | -7.78 | -23.0 | -22.5 | -19.5 | ||||||||
| Depreciation (Networks) | CZK mil | 8.96 | 8.73 | 9.35 | 8.88 | ||||||||
| EBIT (Networks) | CZK mil | -16.7 | -31.7 | -31.9 | -28.4 | ||||||||
| Net Financing Cost (Networks) | CZK mil | 0.116 | 0.336 | 0.046 | 0.046 | ||||||||
| Net Profit (Networks) | CZK mil | -16.9 | -32.1 | -31.9 | -28.5 | ||||||||
| Sales Growth (Networks) | % | ... | 48.1 | -12.5 | 57.3 | ||||||||
| Gross Margin (Networks) | % | 105 | -163 | -199 | -130 | ||||||||
| EBITDA Margin (Networks) | % | -236 | -472 | -528 | -291 | ||||||||
| Net Margin (Networks) | % | -512 | -658 | -748 | -424 |
| simplecell consulting | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| income statement | |||||||||||||
| Sales (Consulting) | CZK mil | ... | ... | ... | 11.5 | ||||||||
| Sales from Hardware (Consulting) | CZK mil | ... | ... | ... | 9.69 | ||||||||
| Price per Device (Consulting) | EUR | ... | ... | 40.0 | 38.0 | ||||||||
| Number of devices connected (Consulting) | '000 | ... | ... | ... | 10.0 | ||||||||
| Sales from Software (Consulting) | CZK mil | ... | ... | ... | 1.66 | ||||||||
| ARPU per Device Serviced (Consulting) | CZK | ... | ... | ... | 166 | ||||||||
| Sales from Consulting (Consulting) | CZK mil | ... | ... | ... | 0.160 | ||||||||
| Cost of Goods & Services (Consulting) | CZK mil | ... | ... | ... | 9.11 | ||||||||
| Gross Profit (Consulting) | CZK mil | ... | ... | ... | 2.40 | ||||||||
| EBITDA (Consulting) | CZK mil | ... | ... | ... | -6.09 | ||||||||
| Depreciation (Consulting) | CZK mil | ... | ... | ... | 0 | ||||||||
| EBIT (Consulting) | CZK mil | ... | ... | ... | -6.09 | ||||||||
| Net Financing Cost (Consulting) | CZK mil | ... | ... | ... | 0 | ||||||||
| Net Profit (Consulting) | CZK mil | ... | ... | ... | -6.09 | ||||||||
| Sales Growth (Consulting) | % | ... | ... | ... | ... | ||||||||
| Gross Margin (Consulting) | % | ... | ... | ... | 20.9 | ||||||||
| EBITDA Margin (Consulting) | % | ... | ... | ... | -52.9 | ||||||||
| Net Margin (Consulting) | % | ... | ... | ... | -52.9 |
Get all company financials in excel:
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Since the end of 2015, stock has appreciated by 0% representing an annual average growth of %. In absolute terms, the value of ...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil in 2020, up 0.521% compared to the previous year. Historically, between 2018 and 2020, the company's net profit reached a high of CZK -16.9 mil in 2018 and a low of CZK -32.1 mil in 2019. The result imp...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil in 2020, up 0.521% compared to the previous year. Historically, between 2018 and 2020, the company's net profit reached a high of CZK -16.9 mil in 2018 and a low of CZK -32.1 mil in 2019. The result imp...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 implying a market capitalization of USD 11.8 mil. Since the end of 2015, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company ros...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 implying a market capitalization of USD 11.8 mil. Since the end of 2015, stock has appreciated by % implying an annual average growth of % In absolute terms, the value of the company ros...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12.5%, respectively, compared to the previous year. This translates into a net margin of -748%. Historically, between 2018 and 2020, ...
By Helgi Library - August 7, 2021
SimpleCell Europe made a net profit of CZK -31.9 mil with revenues of CZK 4.26 mil in 2020, up by 0.521% and down by 12.5%, respectively, compared to the previous year. This translates into a net margin of -748%. Historically, between 2018 and 2020, ...
By Helgi Library - August 7, 2021
SimpleCell Europe's net debt stood at CZK 47.0 mil and accounted for 62.6% of equity at the end of 2020. The ratio is down 10.1 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 72.7% in 2019 and a lo...
By Helgi Library - August 7, 2021
SimpleCell Europe's net debt stood at CZK 47.0 mil and accounted for 62.6% of equity at the end of 2020. The ratio is down 10.1 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 72.7% in 2019 and a lo...
By Helgi Library - August 7, 2021
SimpleCell Europe stock traded at CZK 252 per share at the end 2020 translating into a market capitalization of USD 11.8 mil. Since the end of 2015, the stock has appreciated by 0% representing an annual average growth of %. At the end of 2020, the firm ...
SimpleCell Europe has been growing its sales by 40.2% a year on average in the last 5 years. EBITDA has grown on average by 51.6% a year during that time to total of CZK 183 mil in 2029, or 14.4% of sales. That’s compared to 17.0% average margin seen in last five years.
The company netted CZK 148 mil in 2029 implying ROE of 33.5% and ROCE of 55.0%. Again, the average figures were 40.5% and 43.9%, respectively when looking at the previous 5 years.
SimpleCell Europe’s net debt amounted to CZK -125 mil at the end of 2029, or -31.3% of equity. When compared to EBITDA, net debt was -0.682x, down when compared to average of 0.085x seen in the last 5 years.
SimpleCell Europe stock traded at CZK 252 per share at the end of 2029 resulting in a market capitalization of USD 11.8 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 0.713x and price to earnings (PE) of 2.06x as of 2029.
Helgi Library 
